Covalon Technologies (TSE:COV) has released an update.
Covalon Technologies Ltd., an innovator in medical technology, has scheduled its annual shareholders’ meeting for March 6, 2024, to be conducted virtually. Shareholders will have the opportunity to hear from the new CEO, Brent Ashton, and engage in a Q&A session. The meeting requires registration for participation and voting, with details available on the Company’s website and through TSX Trust.
For further insights into TSE:COV stock, check out TipRanks’ Stock Analysis page.
